icliniq vs Kismet: Revenue, Funding & Team Size Compared
icliniq generates $8.7M in revenue; Kismet generates $6.9M. icliniq is 1.3× bigger than Kismet by revenue. The table below compares icliniq and Kismet on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  icliniqThis company |  Kismet |
|---|---|---|
| Revenue | $8.7M | $6.9M |
| Valuation | $69.3M | Not disclosed |
| Customers | 1M | Not disclosed |
| Team size | 177 | 52 |
| Founded | 2012 | 2023 |
| HQ | Coimbatore, India | South Melbourne, Australia |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
icliniq at a glance
icliniq generates $8.7M in revenue with 177 employees, headquartered in Coimbatore, India.
- Revenue
- $8.7M
- Valuation
- $69.3M
- Customers
- 1M
- Team size
- 177
- Founded
- 2012
Provider of an online doctor consultation platform intended to offer ultimate convenience and premier health care service. The company's online doctor consultation platform provides various channels for contacting doctors such as posting…
Kismet at a glance
Kismet generates $6.9M in revenue with 52 employees, headquartered in South Melbourne, Australia.
- Revenue
- $6.9M
- Team size
- 52
- Founded
- 2023
Kismet is an AI-powered telehealth platform designed to enhance patient engagement and streamline workflows for healthcare providers, particularly in pediatric care.
Other icliniq alternatives
icliniq competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
icliniq vs Kismet: frequently asked questions
Is icliniq or Kismet bigger?
icliniq is the bigger company by revenue, at $8.7M against $6.9M for Kismet.
How much revenue does icliniq make?
icliniq generates $8.7M in annual revenue with a team of 177.
How much revenue does Kismet make?
Kismet generates $6.9M in annual revenue with a team of 52.